Literature DB >> 16931407

The two faces of interleukin 10 in human infectious diseases.

Jean-Louis Mege1, Soraya Meghari, Amélie Honstettre, Christian Capo, Didier Raoult.   

Abstract

Resolution of infections depends on the host's ability to mount a protective immune response. However, an exacerbated response to infections may result in deleterious lesions. Consequently, immunoregulatory mechanisms are needed to control immune response and prevent infection-associated lesions. Interleukin 10 may be a major regulator of innate and adaptive immunity in vitro and in animals, but its role in human infections is still unclear. Review of the published work reveals wide involvement of interleukin 10 in two major features of infectious diseases. On one hand, interleukin 10 prevents the development of immunopathological lesions that result from exacerbated protective immune response to acute and chronic infections. On the other hand, it is critically involved in persistence of bacteria and viruses by interfering with innate and adaptive protective immunity. Moreover, infections induce the expansion of interleukin-10-producing regulatory cells that are involved in protection against allergic diseases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16931407     DOI: 10.1016/S1473-3099(06)70577-1

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


  97 in total

Review 1.  Translating insights from persistent LCMV infection into anti-HIV immunity.

Authors:  Elizabeth B Wilson; David G Brooks
Journal:  Immunol Res       Date:  2010-12       Impact factor: 2.829

2.  Blood dendritic cells suppress NK cell function and increase the risk of leukemia relapse after hematopoietic cell transplantation.

Authors:  Antonio Perez-Martinez; Rekha Iyengar; Kwan Gan; Thirachit Chotsampancharoen; Barbara Rooney; Marti Holladay; Manuel Ramírez; Wing Leung
Journal:  Biol Blood Marrow Transplant       Date:  2010-10-25       Impact factor: 5.742

Review 3.  Macrophage activation by endogenous danger signals.

Authors:  X Zhang; D M Mosser
Journal:  J Pathol       Date:  2008-01       Impact factor: 7.996

4.  Effects of alkylated-chitosan-DNA nanoparticles on the function of macrophages.

Authors:  L X Liu; C N Song; L P Song; H L Zhang; X Dong; X G Leng
Journal:  J Mater Sci Mater Med       Date:  2008-11-20       Impact factor: 3.896

5.  IL-10 directly suppresses CD4 but not CD8 T cell effector and memory responses following acute viral infection.

Authors:  David G Brooks; Kevin B Walsh; Heidi Elsaesser; Michael B A Oldstone
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-26       Impact factor: 11.205

Review 6.  Pathogenesis of implant-associated infection: the role of the host.

Authors:  Werner Zimmerli; Parham Sendi
Journal:  Semin Immunopathol       Date:  2011-05-21       Impact factor: 9.623

Review 7.  The role of dendritic cells in driving genital tract inflammation and HIV transmission risk: are there opportunities to intervene?

Authors:  Muki S Shey; Nigel J Garrett; Lyle R McKinnon; Jo-Ann S Passmore
Journal:  Innate Immun       Date:  2013-11-26       Impact factor: 2.680

8.  Substrains of 129 mice are resistant to Yersinia pestis KIM5: implications for interleukin-10-deficient mice.

Authors:  Joshua K Turner; John L Xu; Richard I Tapping
Journal:  Infect Immun       Date:  2008-10-27       Impact factor: 3.441

9.  Discrete Dynamical Modeling of Influenza Virus Infection Suggests Age-Dependent Differences in Immunity.

Authors:  Ericka Keef; Li Ang Zhang; David Swigon; Alisa Urbano; G Bard Ermentrout; Michael Matuszewski; Franklin R Toapanta; Ted M Ross; Robert S Parker; Gilles Clermont
Journal:  J Virol       Date:  2017-11-14       Impact factor: 5.103

10.  Suppression of cell-mediated immunity following recognition of phagosome-confined bacteria.

Authors:  Keith S Bahjat; Nicole Meyer-Morse; Edward E Lemmens; Jessica A Shugart; Thomas W Dubensky; Dirk G Brockstedt; Daniel A Portnoy
Journal:  PLoS Pathog       Date:  2009-09-04       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.